WHO Draft Working Document on Bioanalytical Method Validation published for Comments
Recommendation
22/23 January 2025
Ensuring Control of Chromatographs, Integration and Results
The World Health Organization (WHO) has published a draft working document entitled Bioanalytical Method Validation and Study Sample Analysis (QAS/23.925).
Content
The "guideline is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification and their application in the analysis of study samples."
It is divided into the following main chapters:
- 1. Introduction
- 2. General principles
- 3. Chromatography
- 4. Ligand binding assays
- 5. Incurred Sample Reanalysis (ISR)
- 6. Partial and cross validation
- 7. Additional considerations
- 8. Documentation
- 9. Glossary
The text is based on the ICH M10 Guidline from May 2022.
Please also see the following articles in our news archiv for further information:
- ICH M10 Guideline on Bioanalytical Method Validation and Study Sample Analysis
- ICH M10 - Draft Guideline on Validation of Bioanalytical Methods published for public Comments
Download and Comments
You can download the document from the WHO Medicines website under "Working documents in public consultation".
Comments should be submitted by 21 January 2024. The WHO asks that comments should be submitted through the online platform PleaseReview™. Further information on the commenting process can be found on the first page of the new document.
Related GMP News
13.01.2025English Translation of Supplement II to the Japanese Pharmacopoeia (JP18) Published
08.01.2025EDQM publishes new FAQ on System Suitability Test (SST)
08.01.2025Pharmeuropa Chapter 2.1.7. Balances for Analytical Purposes published for Comments
08.01.2025How to Guarantee a Complete FDA Inspection Failure
11.12.2024Another FDA Warning Letter Based on Review of Records